Gridai (GRDX) Climbs 12% on Strong Market Day, Surpassing 200‑Day SMA
Gridai (GRDX) jumps 12% to $5.49, breaking its 200‑day SMA—an attractive small‑cap biopharma play poised for growth.
- GRIDAI TECHNOLOGIES CORP
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read


